The generic name for the drug marketed as Vfend is voriconazole [1].
What is Voriconazole used for?
Voriconazole is an antifungal medication used to treat serious fungal infections. It is particularly effective against infections caused by Aspergillus, Candida (including some resistant strains), Scedosporium, and Fusarium species [1]. It is often prescribed for invasive infections in immunocompromised patients, such as those undergoing chemotherapy or organ transplantation, and for other severe fungal diseases like esophageal candidiasis [1].
How does Voriconazole work?
Voriconazole belongs to a class of antifungal drugs called triazoles. It works by inhibiting a key enzyme in the fungal cell membrane synthesis pathway, lanosterol 14-alpha-demethylase. This enzyme is essential for producing ergosterol, a vital component of fungal cell membranes. By disrupting ergosterol production, voriconazole weakens the fungal cell membrane, leading to cell death [1].
When does Voriconazole's patent expire?
The patent landscape for voriconazole is complex and has evolved over time. Information regarding specific patent expiry dates can be found on specialized databases like DrugPatentWatch.com [2]. Generally, patents for innovator drugs expire, allowing for the development and approval of generic versions.
Can generic versions of Voriconazole be sold?
Yes, generic versions of voriconazole can be sold once the relevant patents and exclusivity periods have expired and regulatory approval has been granted by agencies like the U.S. Food and Drug Administration (FDA) [2]. The availability of generic voriconazole can lead to lower treatment costs.
What are the potential side effects of Voriconazole?
Common side effects of voriconazole include visual disturbances, such as blurred vision or changes in color perception, as well as skin rash, headache, nausea, vomiting, diarrhea, and liver enzyme elevations [1]. More serious side effects can occur, including severe liver problems, skin reactions, and neurological effects. Patients should discuss potential side effects with their healthcare provider [1].
How does Voriconazole compare to other antifungals?
Voriconazole is considered a broad-spectrum antifungal and is often used when other antifungals have failed or are not suitable. It demonstrates potent activity against a range of serious fungal pathogens. However, like other antifungals, resistance can emerge. Its specific efficacy and side effect profile are evaluated against other agents like fluconazole, amphotericin B, and echinocandins depending on the type and severity of the fungal infection [1].
Where can I find more information about Voriconazole patents?
Detailed information on patents, including expiry dates and any associated litigation, for voriconazole and its originator product can be found on DrugPatentWatch.com [2]. This resource tracks patent filings and legal challenges that can impact the market exclusivity of pharmaceutical drugs.
*
**Sources:
[1] Vfend (voriconazole) package insert.
[2] DrugPatentWatch.com